Literature DB >> 25863005

Gender differences in planning ability and hepatitis C virus among people who inject drugs.

J D Scheidell1, M R Khan2, L M Clifford3, E M Dunne3, L D Keen4, W W Latimer3.   

Abstract

Hepatitis C virus (HCV) is primarily spread through risky injection practices, including sharing needles, cookers, cottons, rinse water, and the practice of backloading. An important aspect of harm reduction for people who inject drugs (PWID) is to identify factors that contribute to safer injection. Planning ability may influence risky injection practices and gender differences in factors that drive injection practices indicate a need to examine associations between planning and injection behaviors in men versus women. Data from the NEURO-HIV Epidemiologic Study was restricted to those who had ever injected in their lifetime (n=456). Impaired planning ability was assessed with the Tower of London and defined as a standardized total excess move score below the 10th percentile. We used logistic regression to estimate the gender-specific adjusted odds ratios (AOR) and 95% confidence intervals (CI) for associations between impaired planning, each injection practice, and biologically-confirmed HCV. Impaired planning ability was associated with sharing needles (AOR=2.93, 95% CI: 1.33, 6.47), cookers (AOR=3.13, 95% CI: 1.22, 8.02), cottons (AOR=2.89, 95% CI: 1.23, 6.78), rinse water (AOR=2.43, 95% CI: 1.15, 5.14), and backloading (AOR=2.68, 95% CI: 1.26, 5.70) and HCV (AOR=3.42, 95% CI: 1.03, 11.38) among men. Planning ability was not significantly associated with the injection behaviors or HCV among women, suggesting that other factors likely contribute to risky injection practices. Interventions to promote harm reduction among PWID should ascertain and strengthen planning ability. Women may have additional barriers to practicing safe injection beyond impaired planning abilities, which should also be addressed.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gender differences; Hepatitis C virus; Injection drug use

Mesh:

Year:  2015        PMID: 25863005      PMCID: PMC4417386          DOI: 10.1016/j.addbeh.2015.03.019

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  23 in total

1.  Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection.

Authors:  Fasiha Kanwal; Tuyen Hoang; Jennifer R Kramer; Steven M Asch; Matthew Bidwell Goetz; Angelique Zeringue; Peter Richardson; Hashem B El-Serag
Journal:  Gastroenterology       Date:  2010-12-22       Impact factor: 22.682

Review 2.  Cognitive rehabilitation interventions for executive function: moving from bench to bedside in patients with traumatic brain injury.

Authors:  Keith Cicerone; Harvey Levin; James Malec; Donald Stuss; John Whyte
Journal:  J Cogn Neurosci       Date:  2006-07       Impact factor: 3.225

3.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

4.  Previous exposure to HCV among persons born during 1945-1965: prevalence and predictors, United States, 1999-2008.

Authors:  Bryce D Smith; Geoff A Beckett; Anthony Yartel; Deborah Holtzman; Nita Patel; John W Ward
Journal:  Am J Public Health       Date:  2014-01-16       Impact factor: 9.308

5.  [Injecting without getting infected: injectors' strategies to prevent HIV and HCV.]

Authors:  P Mateu-Gelabert; S Friedman; M Sandoval
Journal:  Trastor Adict       Date:  2007-10-01

6.  Correlates of risky injection practices among past-year injection drug users among the US general population.

Authors:  Lauren R Ropelewski; Brent E Mancha; Alicia Hulbert; Abby E Rudolph; Silvia S Martins
Journal:  Drug Alcohol Depend       Date:  2011-01-11       Impact factor: 4.492

7.  Symbiotic goals and the prevention of blood-borne viruses among injection drug users.

Authors:  Samuel R Friedman; Milagros Sandoval; Pedro Mateu-Gelabert; Peter Meylakhs; Don C Des Jarlais
Journal:  Subst Use Misuse       Date:  2011       Impact factor: 2.164

8.  The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

Authors:  Kathleen N Ly; Jian Xing; R Monina Klevens; Ruth B Jiles; John W Ward; Scott D Holmberg
Journal:  Ann Intern Med       Date:  2012-02-21       Impact factor: 25.391

9.  Relationship power, condom use and HIV risk among women in the USA.

Authors:  J Pulerwitz; H Amaro; W De Jong; S L Gortmaker; R Rudd
Journal:  AIDS Care       Date:  2002-12

10.  Control over drug acquisition, preparation and injection: Implications for HIV and HCV risk among young female injection drug users.

Authors:  Karla D Wagner; Jennifer Jackson Bloom; Susan Dodi Hathazi; Bill Sanders; Stephen E Lankenau
Journal:  ISRN Addict       Date:  2013-05-12
View more
  1 in total

1.  Exploring Patient Characteristics and Barriers to Hepatitis C Treatment in Patients on Opioid Substitution Treatment Attending a Community Based Fibro-scanning Clinic.

Authors:  Des Crowley; Walter Cullen; Eamon Laird; John S Lambert; Tina Mc Hugh; Carol Murphy; Marie Claire Van Hout
Journal:  J Transl Int Med       Date:  2017-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.